In our previous studies, we further revealed that stress-activated transcription factor Sp1 upregulates stemness genes (i.e., BMI1 and NANOG) and cellular protectors (i.e., CYP17A1 and SOD2) in GBM cells, contributing to TMZ resistance [17,18,24]. The gene discussed is BMI1; the disease is glioblastoma.